- Home
- Publications
- Publication Search
- Publication Details
Title
The emerging therapeutic role of antibody mixtures
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 13, Issue 7, Pages 953-958
Publisher
Informa Healthcare
Online
2013-05-07
DOI
10.1517/14712598.2013.799133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Qualitative and Semiquantitative Analysis of Composite Mixtures of Antibodies by Native Mass Spectrometry
- (2012) Sara Rosati et al. ANALYTICAL CHEMISTRY
- Validation of the Rapid Fluorescent Focus Inhibition Test for Rabies Virus-Neutralizing Antibodies in Clinical Samples
- (2012) Stefan Kostense et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recombinant antibody mixtures: Production strategies and cost considerations
- (2012) Søren K. Rasmussen et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer
- (2012) Philippe Fournier et al. BIODRUGS
- Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia
- (2012) T. Robak et al. BLOOD
- Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia
- (2012) Tadeusz Robak Future Oncology
- Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor
- (2012) Klaus Koefoed et al. mAbs
- Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma
- (2012) B. D. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein
- (2011) Q. Meng et al. ANALYTICAL BIOCHEMISTRY
- Smarter Drugs
- (2011) Séverine Fagète et al. BIODRUGS
- Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use
- (2011) Torben P. Frandsen et al. BIOTECHNOLOGY AND BIOENGINEERING
- A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia
- (2011) John Schindler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Preclinical Pharmacokinetics and Safety of Sym004: A Synergistic Antibody Mixture Directed against Epidermal Growth Factor Receptor
- (2011) Niels Jørgen Østergaard Skartved et al. CLINICAL CANCER RESEARCH
- Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease
- (2011) C. H. Gutierrez-Aguirre et al. HAEMATOLOGICA
- Generation of stable cell clones expressing mixtures of human antibodies
- (2010) John de Kruif et al. BIOTECHNOLOGY AND BIOENGINEERING
- Improving FCR immunochemotherapy in CLL
- (2010) T. Robak BLOOD
- Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
- (2010) M. W. Pedersen et al. CANCER RESEARCH
- Separation of oxidized variants of a monoclonal antibody by anion-exchange
- (2010) Glen Teshima et al. JOURNAL OF CHROMATOGRAPHY A
- Cell culture processes for monoclonal antibody production
- (2010) Feng Li et al. mAbs
- Single-Batch Production of Recombinant Human Polyclonal Antibodies
- (2010) Lars S. Nielsen et al. MOLECULAR BIOTECHNOLOGY
- Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
- (2009) J. C. Byrd et al. BLOOD
- A Phase 1 Study of Combotox in Pediatric Patients With Refractory B-lineage Acute Lymphoblastic Leukemia
- (2009) Larry Herrera et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy
- (2009) Daniel A. Vallera et al. LEUKEMIA RESEARCH
- Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab
- (2008) Clive S. Zent et al. CANCER
- Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
- (2008) M. Dechant et al. CANCER RESEARCH
- First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
- (2008) A.B.H. Bakker et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started